COMP <GO>
AVGO vs ORCL // FORWARD P/E MULTIPLE
Broadcom Inc. (NASDAQ) VS. Oracle Corporation (NYSE) • 15-METRIC TALLY: AVGO 10
— ORCL 4
▲ FORWARD P/E MULTIPLE LEADER: ORCL
LAST: $326.08 (-5.48%) • MKT CAP: $1.55T
forward-pe
19.0x
LAST: $130.67 (-6.37%) • MKT CAP: $405.97B
forward-pe
16.5x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AVGO VS. ORCL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AVGO | ORCL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 68.77% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 24.73% | 11.39% | +13.34 | AVGO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 34.1x | 17.9x | +16.20 | ORCL | /valuation <GO> |
| Free Cash Flow Yield | 2.55% | -7.07% | +9.62 | AVGO | /fcf-yield <GO> |
| Operating Margin | 48.05% | 32.12% | +15.93 | AVGO | /operating-margins <GO> |
| Net Profit Margin | 42.94% | 26.36% | +16.58 | AVGO | /net-margins <GO> |
| Revenue Growth (YoY) | 48.69% | 21.62% | +27.07 | AVGO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.80% | 1.53% | -0.73 | ORCL | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 12.08 | 1.54 | +10.54 | AVGO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 6/9 | +2.00 | AVGO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 8.98% | 11.57% | -2.59 | AVGO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 40.8 | 45.6 | -4.86 | ORCL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.82 | 1.37 | +0.45 | AVGO | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 19.0x | 16.5x | +2.47 | ORCL | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.55T | $405.97B | $1.14T | AVGO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AVGO REV | ORCL REV | AVGO GROSS % | ORCL GROSS % | AVGO FCF | ORCL FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $67.36B | — | — | — | -$23.69B |
| FY 2025 | $63.89B | $57.40B | 67.8% | — | $26.91B | -$394.0M |
| FY 2024 | $51.57B | $52.96B | 63.0% | — | $19.41B | $11.81B |
| FY 2023 | $35.82B | $49.95B | 68.9% | — | $17.63B | $8.47B |
| FY 2022 | $33.20B | $42.44B | 66.5% | — | $16.31B | $5.03B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AVGO // BETA 1.82
ORCL // BETA 1.37